Subtopic Deep Dive

← Glycosylation and Glycoproteins Research

O-GlcNAc Glycosylation
Research Guide

What is O-GlcNAc Glycosylation?

O-GlcNAc glycosylation is the dynamic, reversible addition of a single β-N-acetylglucosamine (GlcNAc) moiety to serine or threonine residues on nucleocytoplasmic proteins by O-GlcNAc transferase (OGT) and removal by O-GlcNAcase (OGA).

This post-translational modification cycles rapidly and competes with phosphorylation at the same sites (Hart et al., 2007, 1398 citations). Key reviews detail its roles in nutrient sensing, signaling, and chronic diseases like diabetes and neurodegeneration (Hart et al., 2011, 1287 citations; Yang and Qian, 2017, 1152 citations). Over 25 papers in provided lists address its mechanisms and functions.

Curated Papers

Key Challenges

Why It Matters

O-GlcNAcylation integrates nutrient availability with cellular signaling by sensing UDP-GlcNAc levels from the hexosamine biosynthetic pathway, modulating transcription factors and kinases in metabolic diseases (Hart et al., 2011). Elevated O-GlcNAc levels contribute to insulin resistance in diabetes and tau hyperphosphorylation in Alzheimer's disease (Yang and Qian, 2017). Hart et al. (2007) showed its dynamic cycling on over 1,000 proteins, impacting gene expression and stress responses, with inhibitors like Thiamet-G tested for neurodegeneration therapies.

Key Research Challenges

Site Mapping Difficulty

Identifying O-GlcNAc sites remains challenging due to low stoichiometry and overlap with phosphorylation sites, requiring advanced mass spectrometry like ETD fragmentation (Hart et al., 2011). Few antibodies distinguish O-GlcNAc from other modifications, limiting enrichment (Yang and Qian, 2017).

Enzyme Regulation Complexity

OGT and OGA activities are regulated by sugar nucleotides, kinases, and localization, but precise allosteric mechanisms are unclear (Hart et al., 2007). Genetic knockouts reveal lethality, complicating in vivo studies (Yang and Qian, 2017).

Disease Target Validation

Linking hyper-O-GlcNAcylation to diabetes or Alzheimer's pathology needs causal evidence beyond correlations, with conflicting inhibitor outcomes (Hart et al., 2011). Clinical translation stalls due to off-target effects of OGT/OGA modulators.

Essential Papers

Biological roles of oligosaccharides: all of the theories are correct

Ajit Varki · 1993 · Glycobiology · 5.2K citations

Many different theories have been advanced concerning the biological roles of the oligosaccharide units of individual classes of glycoconjugates. Analysis of the evidence indicates that while all o...

Biological roles of glycans

Ajit Varki · 2016 · Glycobiology · 2.5K citations

Simple and complex carbohydrates (glycans) have long been known to play major metabolic, structural and physical roles in biological systems. Targeted microbial binding to host glycans has also bee...

IgG Subclasses and Allotypes: From Structure to Effector Functions

Gestur Vidarsson, Gillian Dekkers, Theo Rispens · 2014 · Frontiers in Immunology · 2.5K citations

Of the five immunoglobulin isotypes, immunoglobulin G (IgG) is most abundant in human serum. The four subclasses, IgG1, IgG2, IgG3, and IgG4, which are highly conserved, differ in their constant re...

Glycosylation in health and disease

Colin Reily, Tyler J. Stewart, Matthew B. Renfrow et al. · 2019 · Nature Reviews Nephrology · 2.0K citations

Siglecs and their roles in the immune system

Paul R. Crocker, James C. Paulson, Ajit Varki · 2007 · Nature reviews. Immunology · 2.0K citations

Heparan Sulfate Proteoglycans

Sandrine Sarrazin, William C. Lamanna, Jeffrey D. Esko · 2011 · Cold Spring Harbor Perspectives in Biology · 1.4K citations

Heparan sulfate proteoglycans are found at the cell surface and in the extracellular matrix, where they interact with a plethora of ligands. Over the last decade, new insights have emerged regardin...

Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins

Gerald W. Hart, Michael P. Housley, Chad Slawson · 2007 · Nature · 1.4K citations

Reading Guide

Foundational Papers

Start with Hart et al. (2007, Nature, 1398 citations) for O-GlcNAc cycling discovery; then Hart et al. (2011, Annual Review of Biochemistry, 1287 citations) for phospho-crosstalk fundamentals.

Recent Advances

Study Yang and Qian (2017, Nature Reviews Molecular Cell Biology, 1152 citations) for emerging functions; cross-reference Varki (2016, Glycobiology, 2514 citations) for glycan context.

Core Methods

Core techniques: OGT/OGA enzymatic assays, click chemistry for labeling, ETD-MS fragmentation, and CRISPR OGT/OGA knockouts (Hart et al., 2007; Yang and Qian, 2017).

How PapersFlow Helps You Research O-GlcNAc Glycosylation

Discover & Search

Research Agent uses searchPapers('O-GlcNAc glycosylation mechanisms') to retrieve Hart et al. (2007, 1398 citations), then citationGraph to map 1,000+ citing papers on cycling dynamics, and findSimilarPapers to uncover related nutrient-sensing studies.

Analyze & Verify

Analysis Agent employs readPaperContent on Hart et al. (2011) to extract phospho-O-GlcNAc crosstalk data, verifyResponse with CoVe to check claims against 10 similar papers, and runPythonAnalysis for statistical comparison of site overlap frequencies using pandas on extracted datasets, with GRADE scoring for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in O-GlcNAc Alzheimer's links via contradiction flagging across reviews, while Writing Agent uses latexEditText for figure captions, latexSyncCitations to integrate Hart et al. (2007), and latexCompile for a review manuscript with exportMermaid diagrams of OGT/OGA cycles.

Use Cases

"Analyze O-GlcNAc site motifs from Hart 2007 mass spec data"

Analysis Agent → runPythonAnalysis (pandas motif frequency plot from readPaperContent data) → matplotlib histogram output with statistical p-values.

"Draft LaTeX review on O-GlcNAc in neurodegeneration citing Yang 2017"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Yang and Qian, 2017) + latexCompile → camera-ready PDF.

"Find GitHub code for O-GlcNAc proteomics analysis"

Research Agent → Code Discovery (paperExtractUrls from Hart et al. 2011 → paperFindGithubRepo → githubRepoInspect) → runnable ETD-MS pipeline scripts.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ O-GlcNAc papers via searchPapers → citationGraph → structured report with GRADE scores on disease roles. DeepScan applies 7-step analysis to Yang and Qian (2017), verifying mechanisms with CoVe checkpoints and runPythonAnalysis on flux models. Theorizer generates hypotheses on O-GlcNAc-phospho switches from Hart et al. (2007, 2011).

Try Doxa for O-GlcNAc Glycosylation Research

Frequently Asked Questions

What defines O-GlcNAc glycosylation?

O-GlcNAc is the addition of single GlcNAc to Ser/Thr by OGT and removal by OGA on nuclear/cytoplasmic proteins, cycling like phosphorylation (Hart et al., 2007).

What are main methods to study O-GlcNAc?

Methods include GlcNAc-specific antibodies, lectin enrichment, ETD-MS for site mapping, and OGT/OGA inhibitors like Thiamet-G (Yang and Qian, 2017; Hart et al., 2011).

What are key papers on O-GlcNAc?

Foundational: Hart et al. (2007, Nature, 1398 citations) on cycling; Hart et al. (2011, 1287 citations) on crosstalk. Recent: Yang and Qian (2017, 1152 citations) on mechanisms.

What open problems exist in O-GlcNAc research?

Challenges include precise site-specific tools, causal roles in diseases, and selective inhibitors without toxicity (Hart et al., 2011; Yang and Qian, 2017).